Trisomy 11 and a Complex t(11;11;22) in a Patient with Acute Myelomonocytic Leukemia (AML-M4) Following Myelodysplasia (MDS): A Cytogenetic Study of a Mechanism of Leukemogenesis

Autor: Bernasconi, P ^*, Cavigliano, P.M, Boni, M, Malcovati, L, Astori, C, Castagnola, C, Pagnucco, G, Vanelli, L, Calatroni, S, Caresana, M, Lazzarino, M, Bernasconi, C

Publikováno v: In Cancer Genetics and Cytogenetics 2000 116(2):111-118

Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis

Autor: Rumi, E, Pietra, D, Pascutto, C, Guglielmelli, P, Martínez Trillos, A, Casetti, I, Colomer, D, Pieri, L, Pratcorona, M, Rotunno, G, Sant'Antonio, E, Bellini, M, Cavalloni, C, Mannarelli, C, Milanesi, C, Boveri, E, Ferretti, V, Astori, C, Rosti, V, Cervantes, F, Barosi, G, Vannucchi, Am, Cazzola, M, Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative Investigators Collaborators Vannucchi AM, Balliu, M, Bartalucci, N, Biamonte, F, Bisognin, A, Bogani, C, Bortoluzzi, S, Bosi, A, Coppe, A, Fanelli, T, Fjerza, R, Loiacono, I, Marchioli, R, Martinelli, S, Masciulli, A, Pancrazzi, A, Paoli, C, Saccoman, C, Spolverini, A, Susini, Mc, Tozzi, L, Azzan, C, Badalucco, S, Balduini, A, Bonetti, E, Campanelli, R, Catarsi, P, Isgrò, Am, Lupo, Ml, Magrini, U, Massa, M, Poletto, V, Villani, L, Ambaglio, I, Bernasconi, P, Casetti, Ic, Catricalà, S, Elena, C, Fugazza, E, Gall, A, Malcovati, L, Ripamonti, F, Rossi, M, Dejana, E, Breviario, F, Corada, M, Erba, Bg, Rambaldi, A, Amaru, A, Barbui, T, Belotti, C, Boroni, C, Ferrari, Ml, Finazzi, G, Finazzi, Mc, Golay, J, Gritti, G, Salmoiraghi, S, Cilloni, Daniela, Campia, V, Carturan, S, Guerrasio, Angelo, Manfredini, R, Bianchi, E, Salati, S, Tagliafico, E, Tenedini, E, Zini, R.

We studied the impact of driver mutations of JAK2, CALR, (calreticulin gene) or MPL on clinical course, leukemic transformation, and survival of patients with primary myelofibrosis (PMF). Of the 617 subjects studied, 399 (64.7%) carried JAK2 (V617F),

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fcc20185ca75ffed69c01238001098b
https://europepmc.org/articles/PMC4133481/

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis

Autor: Passamonti, Francesco, Malabarba, L, Orlandi, E, Pascutto, C, Brusamolino, E, Astori, C, Baratè, C, Canevari, A, Corso, A, Bernasconi, P, Cazzola, M, Lazzarino, M.

Publikováno v: British journal of haematology. 116(4)

Essential thrombocythaemia (ET) is a disease associated with an elevated risk of thrombosis. This study evaluated the efficacy and safety of pipobroman (PB) in the long-term control of ET patients who had, at diagnosis, one or more of the following c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1401f4fc64f77e16dd876a97cbc26f8d
https://pubmed.ncbi.nlm.nih.gov/11886392

Treatment of early-stage Hodgkin's disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity

Autor: Brusamolino E, Lunghi F, Orlandi E, Astori C, Francesco Passamonti, Baraté C, Pagnucco G, Baio A, Franchini P, Lazzarino M, Bernasconi C

Publikováno v: Scopus-Elsevier
Europe PubMed Central

The use of combined modality therapy in early-stage Hodgkin's disease can spare staging laparotomy and reduces the risk of relapse compared to radiation alone. This paper reports on the efficacy and long-term events of a combined modality approach co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1c9dc4c9d870307bba99ab7464653cad
https://pubmed.ncbi.nlm.nih.gov/11025593